Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.39 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.37 |
| ▸ | IL2 | P60568 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7513299 | 0.85 | KDM4E (0.44) | KDM4ELMNAMAPTHTTHRH3 | |
| SCHEMBL7842188 | 0.82 | KDM4E (0.43) | KDM4ELMNAMAPTHTTIL2 | |
| SCHEMBL7934334 | 0.81 | KDM4E (0.45) | KDM4ECHRM1LMNAMAPTHTT | |
| SCHEMBL9119960 | 0.81 | KDM4E (0.39) | KDM4ELMNAMAPTHTTHRH3 | |
| SCHEMBL7112634 | 0.80 | KDM4E (0.53) | KDM4ELMNAMAPTHTTHRH3 | |
| SCHEMBL9607357 | 0.80 | KDM4E (0.41) | KDM4ELMNAMAPTHTT | |
| SCHEMBL20921262 | 0.80 | KDM4E (0.41) | KDM4ELMNAMAPTHTTIL2 | |
| SCHEMBL425368 | 0.78 | KDM4E (0.39) | KDM4ELMNAMAPTHTT | |
| SCHEMBL422793 | 0.78 | KDM4E (0.39) | KDM4ELMNAMAPTHTT | |
| SCHEMBL10835648 | 0.78 | KDM4E (0.50) | KDM4ELMNAMAPTHTTHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010020110-A1 | Production methods of alpha, alpha, alpha-trifluoromethylphenyl-substituted benzoic acid and intermediate therefor | SUMIKA FINE CHEMICALS CO., LTD. (JP) | 2001-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010020110-A1 | Production methods of alpha, alpha, alpha-trifluoromethylphenyl-substituted benzoic acid and intermediate therefor | SLC6A11, CYP4F11, SLC39A11 | FABP4 2657/4885KDM4E 3088/4885FABP5 3203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.